- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 239/14 - Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Patent holdings for IPC class C07C 239/14
Total number of patents in this class: 21
10-year publication summary
|
0
|
0
|
2
|
0
|
2
|
0
|
0
|
2
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Lantern Pharma Inc. | 68 |
4 |
| Generics [UK] Limited | 129 |
2 |
| Versitech Limited | 369 |
2 |
| The Regents of the University of California | 19608 |
1 |
| Pfizer Inc. | 3378 |
1 |
| Japan Science and Technology Agency | 1406 |
1 |
| AF Chemicals | 1 |
1 |
| The Chinese University of Hong Kong | 668 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1319 |
1 |
| GLOBALFOUNDRIES U.S. Inc. | 6435 |
1 |
| Institute of Genetics and Developmental Biology, Chinese Academy of Sciences | 154 |
1 |
| Ishihara Sangyo Kaisha, Ltd. | 662 |
1 |
| Peking University | 1252 |
1 |
| Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences | 63 |
1 |
| LEO Pharma A/S | 446 |
1 |
| Dispoltec B.V. | 5 |
1 |
| Other owners | 0 |